*Investigating the neuro-immune mechanisms of neuroinflammatory disease, spinal cord injury, multiple sclerosis and neuropsychiatric disease.
*Non-Alzheimer’s disease degenerative dementias: Identifying prodromal genetic/familial phenotypes, modifying factors, and protein variations involved in progression (2016-2020).
*Transforming protein quantitation technology to improve cancer diagnosis and treatment decisions 2017/TPG001 (Cancer Institute NSW/Translational Program Grant) (2017-2020).
*Genetic Epidemiology of Melanoma Study (2011-2016).
*Melanoma BioBanking (2014-2015).
*Molecular determinants of melanoma risk, progression and response to treatment (NHMRC Program Grant 402761).
*Sydney Melanoma Unit translational research program (2005-2010).
*Mechanisms controlling the excitability of corneal nociceptor nerve terminals (NHMRC, 2000-2004).
*Peripheral mechanisms involved in autonomic hyperreflexia (NHMRC, 2002-2004).
*Immune-mediated inflammation in dorsal root ganglia after peripheral nerve injury and in sensory neuropathies (2005-2007).
*Cellular mechanism underlying neuronal activation of rat mesenteric and caudal arteries (NHMRC, 2004-2007).